SCHEMBL24031860

SCHEMBL24031860

CCC1(OC)CCN(I)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8373081 0.79 CHRM2 (0.32)
SCHEMBL5987704 0.77
SCHEMBL17465636 0.74 GRIN2D (0.36)
SCHEMBL13451620 0.72
SCHEMBL8252953 0.72
SCHEMBL8266336 0.72
SCHEMBL25628754 0.71 CYP1A2 (0.39)
SCHEMBL23536632 0.71 VNN1 (0.38)
SCHEMBL10062257 0.70
SCHEMBL21451469 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3915992-A1 PDE9 INHIBITOR AND USE THEREOF Transthera Sciences (Nanjing), Inc. (CN) 2021-12-01 EP disclosed
WO-2021231927-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2021-11-18 WO disclosed